1. |
Saxena T, Ali AO, Saxena M. Pathophysiology of essential hypertension: an update. Expert Rev Cardiovasc Ther, 2018, 16(12): 879-887.
|
2. |
Singh M, Mensah GA, Bakris G. Pathogenesis and clinical physiology of hypertension. Cardiol Clin, 2010, 28(4): 545-559.
|
3. |
Muller DN, Kvakan H, Luft FC. Immune-related effects in hypertension and target-organ damage. Curr Opin Nephrol Hypertens, 2011, 20(2): 113-117.
|
4. |
Ceravolo GS, Montezano AC, Jordão MT, et al. An interaction of renin-angiotensin and kallikrein-kinin systems contributes to vascular hypertrophy in angiotensin II-induced hypertension: in vivo and in vitro studies. PLoS One, 2014, 9(11): e111117.
|
5. |
2017 ACC/AHA Hypertension Guideline Writing Committee. Prevention, detection, evaluation, and management of high blood pressure in adults: synopsis of the 2017 American College of Cardiology/American Heart Association hypertension guideline. Ann Intern Med, 2018, 168(5): 351-358.
|
6. |
2017 ACC/AHA Hypertension Guideline Writing Committee. Essential hypertension. Lancet, 2007, 370(9587): 591-603.
|
7. |
Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol, 2020, 16(4): 223-237.
|
8. |
Lawes CM, Vander Hoorn S, Rodgers A, et al. Global burden of blood-pressure-related disease, 2001. Lancet, 2008, 371(9623): 1513-1518.
|
9. |
Vallée A, Safar ME, Blacher J. Essential hypertension: definitions, hemodynamic, clinical and therapeutic review. Presse Med, 2019, 48(1): 19-28.
|
10. |
Makka N, Adam N, Rose D. A study on the prevalence of pathologies of the cervical spine in patients with essential hypertension. J Hyper, 2016, 34(Suppl 1): e130.
|
11. |
Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA, 2003, 289(19): 2560-2572.
|
12. |
Wang X, Bots ML, Yang F, et al. Prevalence of hypertension in China: a systematic review and meta-regression analysis of trends and regional differences. J Hypertens, 2014, 32(10): 1919-1927.
|
13. |
Kalb S, Zaidi HA, Ribas-Nijkerk JC, et al. Persistent outpatient hypertension is independently associated with spinal cord dysfunction and imaging characteristics of spinal cord damage among patients with cervical spondylosis. World Neurosurg, 2015, 84(2): 351-357.
|
14. |
Perdomo-Pantoja A, Chara A, Kalb S, et al. The effect of renin-angiotensin system blockers on spinal cord dysfunction and imaging features of spinal cord compression in patients with symptomatic cervical spondylosis. Spine J, 2020, 20(4): 519-529.
|
15. |
Saccò M, Meschi M, Regolisti G, et al. The relationship between blood pressure and pain. J Clin Hypertens (Greenwich), 2013, 15(8): 600-605.
|
16. |
Seravalle G, Grassi G. Sympathetic nervous system and hypertension: new evidences. Auton Neurosci, 2022, 238: 102954.
|
17. |
Perdomo-Pantoja A, Chara A, Liu A, et al. Surgical decompression for cervical spondylotic myelopathy in patients with associated hypertension: a single-center retrospective cohort and systematic review of the literature. World Neurosurg, 2021, 155: e119-e130.
|
18. |
Peng B, Pang X, Li D, et al. Cervical spondylosis and hypertension: a clinical study of 2 cases. Medicine (Baltimore), 2015, 94(10): e618.
|
19. |
Yang L, Yang C, Pang X, et al. Cervical decompression surgery for cervical spondylotic myelopathy and concomitant hypertension: a multicenter prospective cohort study. Spine (Phila Pa 1976), 2017, 42(12): 903-908.
|
20. |
Katikar MD, Katikar DB, Sharma R. Effect of decompressive cervical spine surgery on hypertension in patients with cervical spondylotic myelopathy - a retrospective observational study. Indian J Anaesth, 2022, 66(Suppl 3): S169-S172.
|
21. |
Sharma R, Garg K, Agrawal S, et al. Atypical symptoms of cervical spondylosis: is anterior cervical discectomy and fusion useful. - an institutional experience. Neurol India, 2021, 69(3): 595-601.
|
22. |
Liu H, Ploumis A. Cervicogenic hypertension-a possible etiology and pathogenesis of essential hypertension. Hypothesis, 2012, 10: 1.
|
23. |
Garg K, Aggarwal A. Effect of cervical decompression on atypical symptoms cervical spondylosis-a narrative review and meta-analysis. World Neurosurg, 2022, 157: 207-217.
|
24. |
Lawlor DA, Harbord RM, Sterne JA, et al. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med, 2008, 27(8): 1133-1163.
|
25. |
Hartwig FP, Borges MC, Horta BL, et al. Inflammatory biomarkers and risk of schizophrenia: a 2-sample Mendelian randomization study. JAMA Psychiatry, 2017, 74(12): 1226-1233.
|
26. |
Sang N, Li BH, Zhang MY, et al. Bidirectional causal relationship between depression and frailty: a univariate and multivariate Mendelian randomisation study. Age Ageing, 2023, 52(7): afad113.
|
27. |
Soremekun O, Musanabaganwa C, Uwineza A, et al. A Mendelian randomization study of genetic liability to post-traumatic stress disorder and risk of ischemic stroke. Transl Psychiatry, 2023, 13(1): 237.
|
28. |
Smith GD, Lawlor DA, Harbord R, et al. Clustered environments and randomized genes: a fundamental distinction between conventional and genetic epidemiology. PLoS Med, 2007, 4(12): e352.
|
29. |
Emdin CA, Khera AV, Kathiresan S. Mendelian randomization. JAMA, 2017, 318(19): 1925-1926.
|
30. |
Burgess S, Thompson SG. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol, 2011, 40(3): 755-764.
|
31. |
周学龙, 何心愉, 马斗文, 等. 颈椎病与高血压的相关性研究概况. 广西中医药, 2022, 45(5): 71-74.
|
32. |
于娟, 赵晓平, 范小璇, 等. 颈源性高血压病因病理研究进展. 实用心脑肺血管病杂志, 2021, 29(1): 128-133.
|
33. |
Li ZQ, Zhao YP, Jia WY, et al. Surgical treatment of cervical spondylotic myelopathy associated hypertension--a retrospective study of 309 patients. PLoS One, 2015, 10(7): e0133828.
|
34. |
Li P, Wei Z, Zhang H, et al. Effects of decompressive operation on cardiac autonomic regulation in patients with cervical spondylotic myelopathy: analysis of blood pressure, heart rate, and heart rate variability. Eur Spine J, 2019, 28(8): 1864-1871.
|
35. |
Liu H, Wang HB, Yue L, et al. Effects of decompressive cervical surgery on blood pressure in cervical spondylosis patients with hypertension: a time series cohort study. Int J Spine Surg, 2021, 15(4): 683-691.
|
36. |
Li CY, Lin WC, Lu CY, et al. Prevalence of pain in community-dwelling older adults with hypertension in the United States. Sci Rep, 2022, 12(1): 8387.
|
37. |
Hamam MS, Kunjummen E, Hussain MS, et al. Anxiety, depression, and pain: considerations in the treatment of patients with uncontrolled hypertension. Curr Hypertens Rep, 2020, 22(12): 106.
|
38. |
Wang X, Ju J, Xu H. Nondrug therapies for hypertensive patients complicated with cervical spondylosis: a systematic review and meta-analysis. Medicine (Baltimore), 2020, 99(5): e19006.
|
39. |
许建美, 杨佳曼, 梁满光, 等. 低头摇正法联合颈三针治疗颈源性高血压的临床观察. 广州中医药大学学报, 2023, 40(6): 1414-1419.
|
40. |
Guan H, Zhu H, Gao J, et al. A systematic review of Tuina for cervical hypertension: a protocol for systematic review and meta-analysis. Medicine (Baltimore), 2022, 101(40): e30699.
|
41. |
Lotan R, Oron A, Anekstein Y, et al. Lumbar stenosis and systemic diseases: is there any relevance. J Spinal Disord Tech, 2008, 21(4): 247-251.
|
42. |
Teraguchi M, Yoshimura N, Hashizume H, et al. Metabolic syndrome components are associated with intervertebral disc degeneration: the wakayama spine study. PLoS One, 2016, 11(2): e0147565.
|
43. |
Jhawar BS, Fuchs CS, Colditz GA, et al. Cardiovascular risk factors for physician-diagnosed lumbar disc herniation. Spine J, 2006, 6(6): 684-691.
|
44. |
Libby P, Buring JE, Badimon L, et al. Atherosclerosis. Nat Rev Dis Primers, 2019, 5(1): 56.
|
45. |
Kauppila LI. Atherosclerosis and disc degeneration/low-back pain--a systematic review. Eur J Vasc Endovasc Surg, 2009, 37(6): 661-670.
|
46. |
Hangai M, Kaneoka K, Kuno S, et al. Factors associated with lumbar intervertebral disc degeneration in the elderly. Spine J, 2008, 8(5): 732-740.
|
47. |
Dowdell J, Erwin M, Choma T, et al. Intervertebral disk degeneration and repair. Neurosurgery, 2017, 80(3S): S46-S54.
|